🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 005083100
- IPO
- 8/13/2024 · $8.00/share
Business: Actuate Therapeutics, Inc s a clinical-stage biopharmaceutical company dedicated to developing therapies for cancers with high unmet needs. The company’s product candidate, elraglusib is a small molecule GSK-3 inhibitor designed to restore balance in the NF-κB pathway, effectively reducing inflammation, chemoresistance, and tumor progression.
Company Contact
- CEO
- Daniel M. Schmitt
- CFO
- Paul Lytle
- Headquarters
- 1751 River Run, Suite 400, Fort Worth, TX 76107
- Phone
- 817-887-8455
- Investor Relations
- Mike Moyer, LifeSci Advisors · 617-308-4306